期刊
NEURAL REGENERATION RESEARCH
卷 16, 期 9, 页码 1730-1739出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1673-5374.306066
关键词
dopamine; epigenetics; gene therapies; glutamate receptor; levodopa; molecular chaperones; monoamine oxidase B; mucuna alpha-synuclein; Parkinson's disease; striatum; substantia nigra
资金
- UGC Dr. D.S. Kothari Postdoctoral Scheme [No-F.42/2006 (BSR)/BL/19-20/0032]
Parkinson's disease is a debilitating brain disease with limited treatment options, highlighting the need for novel drug targets to improve patient health. Natural products may play a critical role in controlling the progression of Parkinson's disease.
Parkinson's disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review, we have compiled the information covering limitations of current therapeutic options in PD, novel drug targets for PD, and finally, the role of some critical beneficial natural products to control the progression of PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据